Cargando…

Palmitic Acid Methyl Ester Induces G(2)/M Arrest in Human Bone Marrow-Derived Mesenchymal Stem Cells via the p53/p21 Pathway

Bone marrow-derived mesenchymal cells (BM-MSCs) are able to differentiate into adipocytes, which can secrete adipokines to affect BM-MSC proliferation and differentiation. Recent evidences indicated that adipocytes can secrete fatty acid metabolites, such as palmitic acid methyl ester (PAME), which...

Descripción completa

Detalles Bibliográficos
Autores principales: Lin, Jian-Hong, Ting, Pei-Ching, Lee, Wen-Sen, Chiu, Hung-Wen, Chien, Chun-An, Liu, Chin-Hung, Sun, Li-Yi, Yang, Kun-Ta
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6915012/
https://www.ncbi.nlm.nih.gov/pubmed/31885624
http://dx.doi.org/10.1155/2019/7606238
_version_ 1783479934725914624
author Lin, Jian-Hong
Ting, Pei-Ching
Lee, Wen-Sen
Chiu, Hung-Wen
Chien, Chun-An
Liu, Chin-Hung
Sun, Li-Yi
Yang, Kun-Ta
author_facet Lin, Jian-Hong
Ting, Pei-Ching
Lee, Wen-Sen
Chiu, Hung-Wen
Chien, Chun-An
Liu, Chin-Hung
Sun, Li-Yi
Yang, Kun-Ta
author_sort Lin, Jian-Hong
collection PubMed
description Bone marrow-derived mesenchymal cells (BM-MSCs) are able to differentiate into adipocytes, which can secrete adipokines to affect BM-MSC proliferation and differentiation. Recent evidences indicated that adipocytes can secrete fatty acid metabolites, such as palmitic acid methyl ester (PAME), which is able to cause vasorelaxation and exerts anti-inflammatory effects. However, effects of PAME on BM-MSC proliferation remain unclear. The aim of this study was to investigate the effect of PAME on human BM-MSC (hBM-MSC) proliferation and its underlying molecular mechanisms. hBM-MSCs were treated with PAME for 48 h and then subjected to various analyses. The results from the present study show that PAME significantly reduced the levels of G(2)/M phase regulatory proteins, cyclin-dependent kinase 1 (Cdk1), and cyclin B1 and inhibited proliferation in hBM-MSCs. Moreover, the level of Mdm2 protein decreased, while the levels of p21 and p53 protein increased in the PAME-treated hBM-MSCs. However, PAME treatment did not significantly affect apoptosis/necrosis, ROS generation, and the level of Cdc25C protein. PAME also induced intracellular acidosis and increased intracellular Ca(2+) levels. Cotreatment with PAME and Na(+)/H(+) exchanger inhibitors together further reduced the intracellular pH but did not affect the PAME-induced decreases of cell proliferation and increases of the cell population at the G(2)/M phase. Cotreatment with PAME and a calcium chelator together inhibited the PAME-increased intracellular Ca(2+) levels but did not affect the PAME-induced cell proliferation inhibition and G(2)/M cell cycle arrest. Moreover, the half-life of p53 protein was prolonged in the PAME-treated hBM-MSCs. Taken together, these results suggest that PAME induced p53 stabilization, which in turn increased the levels of p53/p21 proteins and decreased the levels of Cdk1/cyclin B1 proteins, thereby preventing the activation of Cdk1, and eventually caused cell cycle arrest at the G(2)/M phase. The findings from the present study might help get insight into the physiological roles of PAME in regulating hBM-MSC proliferation.
format Online
Article
Text
id pubmed-6915012
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-69150122019-12-29 Palmitic Acid Methyl Ester Induces G(2)/M Arrest in Human Bone Marrow-Derived Mesenchymal Stem Cells via the p53/p21 Pathway Lin, Jian-Hong Ting, Pei-Ching Lee, Wen-Sen Chiu, Hung-Wen Chien, Chun-An Liu, Chin-Hung Sun, Li-Yi Yang, Kun-Ta Stem Cells Int Research Article Bone marrow-derived mesenchymal cells (BM-MSCs) are able to differentiate into adipocytes, which can secrete adipokines to affect BM-MSC proliferation and differentiation. Recent evidences indicated that adipocytes can secrete fatty acid metabolites, such as palmitic acid methyl ester (PAME), which is able to cause vasorelaxation and exerts anti-inflammatory effects. However, effects of PAME on BM-MSC proliferation remain unclear. The aim of this study was to investigate the effect of PAME on human BM-MSC (hBM-MSC) proliferation and its underlying molecular mechanisms. hBM-MSCs were treated with PAME for 48 h and then subjected to various analyses. The results from the present study show that PAME significantly reduced the levels of G(2)/M phase regulatory proteins, cyclin-dependent kinase 1 (Cdk1), and cyclin B1 and inhibited proliferation in hBM-MSCs. Moreover, the level of Mdm2 protein decreased, while the levels of p21 and p53 protein increased in the PAME-treated hBM-MSCs. However, PAME treatment did not significantly affect apoptosis/necrosis, ROS generation, and the level of Cdc25C protein. PAME also induced intracellular acidosis and increased intracellular Ca(2+) levels. Cotreatment with PAME and Na(+)/H(+) exchanger inhibitors together further reduced the intracellular pH but did not affect the PAME-induced decreases of cell proliferation and increases of the cell population at the G(2)/M phase. Cotreatment with PAME and a calcium chelator together inhibited the PAME-increased intracellular Ca(2+) levels but did not affect the PAME-induced cell proliferation inhibition and G(2)/M cell cycle arrest. Moreover, the half-life of p53 protein was prolonged in the PAME-treated hBM-MSCs. Taken together, these results suggest that PAME induced p53 stabilization, which in turn increased the levels of p53/p21 proteins and decreased the levels of Cdk1/cyclin B1 proteins, thereby preventing the activation of Cdk1, and eventually caused cell cycle arrest at the G(2)/M phase. The findings from the present study might help get insight into the physiological roles of PAME in regulating hBM-MSC proliferation. Hindawi 2019-12-01 /pmc/articles/PMC6915012/ /pubmed/31885624 http://dx.doi.org/10.1155/2019/7606238 Text en Copyright © 2019 Jian-Hong Lin et al. http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Lin, Jian-Hong
Ting, Pei-Ching
Lee, Wen-Sen
Chiu, Hung-Wen
Chien, Chun-An
Liu, Chin-Hung
Sun, Li-Yi
Yang, Kun-Ta
Palmitic Acid Methyl Ester Induces G(2)/M Arrest in Human Bone Marrow-Derived Mesenchymal Stem Cells via the p53/p21 Pathway
title Palmitic Acid Methyl Ester Induces G(2)/M Arrest in Human Bone Marrow-Derived Mesenchymal Stem Cells via the p53/p21 Pathway
title_full Palmitic Acid Methyl Ester Induces G(2)/M Arrest in Human Bone Marrow-Derived Mesenchymal Stem Cells via the p53/p21 Pathway
title_fullStr Palmitic Acid Methyl Ester Induces G(2)/M Arrest in Human Bone Marrow-Derived Mesenchymal Stem Cells via the p53/p21 Pathway
title_full_unstemmed Palmitic Acid Methyl Ester Induces G(2)/M Arrest in Human Bone Marrow-Derived Mesenchymal Stem Cells via the p53/p21 Pathway
title_short Palmitic Acid Methyl Ester Induces G(2)/M Arrest in Human Bone Marrow-Derived Mesenchymal Stem Cells via the p53/p21 Pathway
title_sort palmitic acid methyl ester induces g(2)/m arrest in human bone marrow-derived mesenchymal stem cells via the p53/p21 pathway
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6915012/
https://www.ncbi.nlm.nih.gov/pubmed/31885624
http://dx.doi.org/10.1155/2019/7606238
work_keys_str_mv AT linjianhong palmiticacidmethylesterinducesg2marrestinhumanbonemarrowderivedmesenchymalstemcellsviathep53p21pathway
AT tingpeiching palmiticacidmethylesterinducesg2marrestinhumanbonemarrowderivedmesenchymalstemcellsviathep53p21pathway
AT leewensen palmiticacidmethylesterinducesg2marrestinhumanbonemarrowderivedmesenchymalstemcellsviathep53p21pathway
AT chiuhungwen palmiticacidmethylesterinducesg2marrestinhumanbonemarrowderivedmesenchymalstemcellsviathep53p21pathway
AT chienchunan palmiticacidmethylesterinducesg2marrestinhumanbonemarrowderivedmesenchymalstemcellsviathep53p21pathway
AT liuchinhung palmiticacidmethylesterinducesg2marrestinhumanbonemarrowderivedmesenchymalstemcellsviathep53p21pathway
AT sunliyi palmiticacidmethylesterinducesg2marrestinhumanbonemarrowderivedmesenchymalstemcellsviathep53p21pathway
AT yangkunta palmiticacidmethylesterinducesg2marrestinhumanbonemarrowderivedmesenchymalstemcellsviathep53p21pathway